L. major infection: Natural history and determinants of resistance
L. major infection: Natural history and determinants of resistance
批准号:
7677363
负责人:
AFIF BEN SALAH
金额:
$13.28万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2012-07-31
关键词:
AddressAgeAge DistributionAntibodiesAntigensAreaAtrophicBiteBurn injuryCharacteristicsCicatrixClinicalCohort StudiesColorCommunitiesConditionCosmeticsCutaneousCutaneous LeishmaniasisDevelopmentDiseaseEconomic FactorsEducational BackgroundEnvironmental Risk FactorEvaluationExposure toFailureFamilyFutureGenderGoalsHeadHeightHeterogeneityHouseholdHyperpigmentationHypersensitivity skin testingHypertrophyHypopigmentationImmuneImmune responseImmunologic FactorsIncidenceIncomeIndividualInfectionInterventionJirdKnowledgeLeishmaniaLeishmaniasisLesionLifeLocationMeasuresNatural HistoryNatural ResistanceOlder PopulationOutcomeParasitesPatientsPharmaceutical PreparationsPlastic SurgeonPolicy MakerPopulationPredictive ValuePredispositionPrevalencePreventionPrevention strategyPreventivePrimary PreventionPropertyProspective StudiesPsammomysPublic HealthRateReactionRecording of previous eventsRecurrenceRelative (related person)Research DesignResearch PersonnelResistanceRiskRisk FactorsSalivaSamplingSand FliesScoreSeveritiesSeverity of illnessSkinSystemTestingTimeUlcerVaccine Clinical TrialVaccinesWeightage groupbasecohortconceptcytotoxicdisease transmissiondrug efficacyfollow-upimprovedleishmaninoutcome forecastpressureprogramsprospectivesizetooltransmission processvaccine evaluationvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Determinants of susceptibility/resistance and natural history of L. major infection in endemic foci include
environmental and host related risk factors. Our long term goal is to elucidate the natural history of L. major
infection and to weight the relative importance of host related risk factors of cutaneous leishmaniasis (CL)
emergence and severity considering the confounding effect of environmental factors influencing exposure.
The specific hypothesis is that the natural history of L. major infection and the clinical expression of
cutaneous leishmaniasis varies according to past history of transmission and to the type of biotope in the
study area. Host related immunological surrogates of protection other than leishmanin skin test (LSI)prior to
transmission might explain resistance to the disesase and might be used as efficacy criteria in the context of
vaccines' evaluation in the field. Based on these observations the focus of project 1 is to refine bya
prospective cohort population based study the estimation of the epidemetric parameters and clinical
description of disease and transmission dynamics to improve the understanding of natural history of
Leishmania (L.)major infection and its determinants. The specific aims are to:
1. Elucidate epidemetric parameters of L. major infection. We will use
leishmanin skin test (LST) and clinical observations, the incidence of CL versus asymptomatic infection
(LST+/lesions-) in a two years prospective study in order to determine: i) the prevalence of LST positivity, ii)
the rate of conversion and reversion of LST, iii)the incidence of symptomatic/ asymptomatic infection, iv)
the score severity of disease, v) the rate of recurrence, vi) the predictive value and the protection fraction of
LST positivity.
2. To evaluate the relative importance of immune host related factors and environmental on the natural
history and clinical expression of the disease. These include LST, cytotoxic immune response and antibodies
against sand flies' saliva antigens, distance to colonized area by reservoirs, characteristics of dwelling and
its compound, socio-economic factors and pathogenic properties of L. major isolates.
3. To develop and validate scales for severity of cutaneous lesions and quality of resulting scars. The scale
items include size of the ulcer, color (hypopigmentation, hyperpigmentation, normal skin) and height.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strengthening the surveillance and control of Influenza program implemented in Tu
-
批准号:8729356
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2013
-
负责人:AFIF BEN SALAH
-
依托单位:
Strengthening the surveillance and control of Influenza program implemented in Tu
-
批准号:8664076
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2013
-
负责人:AFIF BEN SALAH
-
依托单位:
Administrative Core
-
批准号:8321824
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2011
-
负责人:AFIF BEN SALAH
-
依托单位:
Administrative Core
-
批准号:7693939
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2008
-
负责人:AFIF BEN SALAH
-
依托单位:
Administrative Core
-
批准号:7284548
-
项目类别:
-
资助金额:$3.78万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Key Determinants Of The Natural History Of Leishmania major Infection
-
批准号:7938640
-
项目类别:
-
资助金额:$49.45万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Key Determinants Of The Natural History Of Leishmania major Infection
-
批准号:7677367
-
项目类别:
-
资助金额:$50.27万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Key Determinants Of The Natural History Of Leishmania major Infection
-
批准号:7268330
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
L. major infection: Natural history and determinants of resistance
-
批准号:7284542
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Key Determinants Of The Natural History Of Leishmania major Infection
-
批准号:7484247
-
项目类别:
-
资助金额:$48.92万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Key Determinants Of The Natural History Of Leishmania major Infection
-
批准号:8127871
-
项目类别:
-
资助金额:$44.21万
-
财政年份:2007
-
负责人:AFIF BEN SALAH
-
依托单位:
Administrative Core
-
批准号:8127870
-
项目类别:
-
资助金额:$2.74万
-
财政年份:--
-
负责人:AFIF BEN SALAH
-
依托单位:
L. major infection: Natural history and determinants of resistance
-
批准号:7938635
-
项目类别:
-
资助金额:$14.54万
-
财政年份:--
-
负责人:AFIF BEN SALAH
-
依托单位:
Administrative Core
-
批准号:7938639
-
项目类别:
-
资助金额:$2.79万
-
财政年份:--
-
负责人:AFIF BEN SALAH
-
依托单位:
L. major infection: Natural history and determinants of resistance
-
批准号:8127866
-
项目类别:
-
资助金额:$15.57万
-
财政年份:--
-
负责人:AFIF BEN SALAH
-
依托单位:
L. major infection: Natural history and determinants of resistance
-
批准号:8321820
-
项目类别:
-
资助金额:$14.91万
-
财政年份:--
-
负责人:AFIF BEN SALAH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: